About iMedrix
iMedrix is a company based in Bengaluru (India) founded in 2015 by Srikanth Jadcherla, Rajaram Shastri, and Venkatakrishna Araveti. The company has 25 employees as of March 29, 2024. iMedrix offers products and services including KardioScreen™. iMedrix operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, Tricog, CoachCare and BioIntelliSense, among others.
- Headquarter Bengaluru, India
- Employees 25 as on 29 Mar, 2024
- Founders Srikanth Jadcherla, Rajaram Shastri, Venkatakrishna Araveti
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imedrix Systems Private Limited
- Date of Incorporation 01 Mar, 2016
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$798.75 K (USD)12.3as on Mar 31, 2022
-
Net Profit
$54.49 K (USD)87.72as on Mar 31, 2022
-
EBITDA
$91.62 K (USD)29.45as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
25
as on Mar 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of iMedrix
iMedrix offers a comprehensive portfolio of products and services, including KardioScreen™.
Mobile solution for 12/6 Lead ECG monitoring and remote diagnosis.
People of iMedrix
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of iMedrix
Investors in iMedrix
iMedrix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DEFTA Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology and healthcare companies are funded by DEFTA Partners.
|
Locked | Locked | Locked |
Investor details for iMedrix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iMedrix
Investment portfolio details for iMedrix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iMedrix
Detailed financials for iMedrix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imedrix Comparisons
Peer comparison for iMedrix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iMedrix
iMedrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, Tricog, CoachCare and BioIntelliSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
AI-powered cardiac diagnostic solutions are provided for care pathways.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
AI-powered echocardiography analysis for cardiovascular disease detection is provided.
|
Detailed competitors of iMedrix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imedrix
Complete news archive for iMedrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iMedrix
iMedrix was founded in 2015 and raised its 1st funding round 5 years after it was founded.
iMedrix is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Srikanth Jadcherla is the current CEO of iMedrix. They have also founded this company.
As of Mar 29, 2024, the latest employee count at iMedrix is 25.
Annual revenue of iMedrix is $798.75K as on Mar 31, 2022.
iMedrix was founded in 2015 in Bengaluru, India, focusing on the healthtech sector. Portable ECG recording devices, such as KardioScreen, are developed for healthcare providers. ECG readings are captured by patients placing fingers on the device, with real-time cardiac impulses recorded, analyzed, and transmitted via cloud technology. Operations emphasize data security and integration for clinical use.
iMedrix's top competitors include Endotronix, Tricog and Ultromics.
iMedrix offers KardioScreen™.
iMedrix has 1 investor. Key investors include DEFTA Partners.